On the financing side I would bet they are setting up a $60 million loan vehicle they could potentially draw from if necessary. Having a guaranteed loan to draw from that would cover expenses for a year and a business plan that could cover the loan should satisfy uplisting requirements. Of course this would hinge on FDA approval for COVID-19.